SYNJ2 and prostate carcinoma: Genetic variation in SYNJ2 is widely found in human diseases, such as reduced cognitive ability [7], Alzheimer’s disease and depression [8], medulloblastoma [9], colorectal cancer [10], prostate cancer [11], hairy cell leukemia [12], glioma [13], and breast cancer [14].